GO:0003012 | muscle system process | 3.12% (2/64) | 13.2 | 0.0 | 2e-06 |
GO:0006936 | muscle contraction | 3.12% (2/64) | 13.2 | 0.0 | 2e-06 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 6.25% (4/64) | 7.24 | 0.0 | 2e-06 |
GO:0061135 | endopeptidase regulator activity | 6.25% (4/64) | 6.85 | 0.0 | 3e-06 |
GO:0030414 | peptidase inhibitor activity | 6.25% (4/64) | 6.9 | 0.0 | 3e-06 |
GO:0004866 | endopeptidase inhibitor activity | 6.25% (4/64) | 6.9 | 0.0 | 3e-06 |
GO:0061134 | peptidase regulator activity | 6.25% (4/64) | 6.7 | 0.0 | 3e-06 |
GO:0003008 | system process | 3.12% (2/64) | 11.87 | 0.0 | 4e-06 |
GO:0005615 | extracellular space | 6.25% (4/64) | 6.15 | 0.0 | 1.2e-05 |
GO:0140678 | molecular function inhibitor activity | 6.25% (4/64) | 5.45 | 2e-06 | 6.8e-05 |
GO:0004857 | enzyme inhibitor activity | 6.25% (4/64) | 5.47 | 2e-06 | 7.3e-05 |
GO:0004197 | cysteine-type endopeptidase activity | 4.69% (3/64) | 5.78 | 2.5e-05 | 0.000638 |
GO:0003674 | molecular_function | 59.38% (38/64) | 0.75 | 7.7e-05 | 0.001819 |
GO:0006692 | prostanoid metabolic process | 1.56% (1/64) | 13.2 | 0.000107 | 0.001936 |
GO:0006693 | prostaglandin metabolic process | 1.56% (1/64) | 13.2 | 0.000107 | 0.001936 |
GO:0047522 | 15-oxoprostaglandin 13-oxidase activity | 1.56% (1/64) | 13.2 | 0.000107 | 0.001936 |
GO:0005861 | troponin complex | 1.56% (1/64) | 13.2 | 0.000107 | 0.001936 |
GO:0006690 | icosanoid metabolic process | 1.56% (1/64) | 12.2 | 0.000213 | 0.003656 |
GO:0033559 | unsaturated fatty acid metabolic process | 1.56% (1/64) | 11.61 | 0.000319 | 0.005196 |
GO:0005764 | lysosome | 3.12% (2/64) | 6.1 | 0.000407 | 0.005987 |
GO:0044391 | ribosomal subunit | 4.69% (3/64) | 4.42 | 0.000394 | 0.006092 |
GO:0005576 | extracellular region | 4.69% (3/64) | 4.35 | 0.000458 | 0.006437 |
GO:0030234 | enzyme regulator activity | 6.25% (4/64) | 3.4 | 0.000587 | 0.007253 |
GO:0005840 | ribosome | 4.69% (3/64) | 4.24 | 0.000566 | 0.007289 |
GO:0000323 | lytic vacuole | 3.12% (2/64) | 5.89 | 0.000547 | 0.007352 |
GO:0051603 | proteolysis involved in protein catabolic process | 6.25% (4/64) | 3.3 | 0.000756 | 0.008053 |
GO:0004312 | fatty acid synthase activity | 1.56% (1/64) | 10.39 | 0.000745 | 0.008225 |
GO:0004175 | endopeptidase activity | 6.25% (4/64) | 3.33 | 0.000695 | 0.008262 |
GO:0098772 | molecular function regulator activity | 6.25% (4/64) | 3.31 | 0.000744 | 0.008516 |
GO:0008234 | cysteine-type peptidase activity | 4.69% (3/64) | 4.05 | 0.000833 | 0.008584 |
GO:0003735 | structural constituent of ribosome | 4.69% (3/64) | 4.01 | 0.000889 | 0.008865 |
GO:0006412 | translation | 4.69% (3/64) | 3.84 | 0.001266 | 0.012226 |
GO:0043043 | peptide biosynthetic process | 4.69% (3/64) | 3.71 | 0.001619 | 0.015162 |
GO:0016491 | oxidoreductase activity | 10.94% (7/64) | 1.97 | 0.00205 | 0.01863 |
GO:0010476 | gibberellin mediated signaling pathway | 1.56% (1/64) | 8.74 | 0.00234 | 0.019032 |
GO:0009740 | gibberellic acid mediated signaling pathway | 1.56% (1/64) | 8.74 | 0.00234 | 0.019032 |
GO:0006508 | proteolysis | 7.81% (5/64) | 2.46 | 0.002171 | 0.019164 |
GO:0022625 | cytosolic large ribosomal subunit | 3.12% (2/64) | 4.85 | 0.002246 | 0.019277 |
GO:0046906 | tetrapyrrole binding | 6.25% (4/64) | 2.83 | 0.002506 | 0.019359 |
GO:0020037 | heme binding | 6.25% (4/64) | 2.84 | 0.002445 | 0.019376 |
GO:0006518 | peptide metabolic process | 4.69% (3/64) | 3.46 | 0.002671 | 0.020131 |
GO:0015934 | large ribosomal subunit | 3.12% (2/64) | 4.57 | 0.003305 | 0.024314 |
GO:0043604 | amide biosynthetic process | 4.69% (3/64) | 3.32 | 0.003482 | 0.02502 |
GO:0005198 | structural molecule activity | 4.69% (3/64) | 3.29 | 0.003649 | 0.025628 |
GO:0007015 | actin filament organization | 3.12% (2/64) | 4.15 | 0.005786 | 0.038868 |
GO:0008233 | peptidase activity | 6.25% (4/64) | 2.47 | 0.005976 | 0.039292 |
GO:0004556 | alpha-amylase activity | 1.56% (1/64) | 7.44 | 0.005735 | 0.039381 |
GO:0051015 | actin filament binding | 3.12% (2/64) | 4.1 | 0.006172 | 0.039735 |
GO:0003779 | actin binding | 3.12% (2/64) | 3.85 | 0.008689 | 0.045509 |
GO:0005773 | vacuole | 3.12% (2/64) | 3.98 | 0.007247 | 0.045698 |
GO:0032501 | multicellular organismal process | 3.12% (2/64) | 3.86 | 0.008588 | 0.045753 |
GO:0050790 | regulation of catalytic activity | 3.12% (2/64) | 3.86 | 0.008588 | 0.045753 |
GO:0030312 | external encapsulating structure | 3.12% (2/64) | 3.81 | 0.009088 | 0.046804 |
GO:0008150 | biological_process | 42.19% (27/64) | 0.6 | 0.009404 | 0.046866 |
GO:0043228 | non-membrane-bounded organelle | 6.25% (4/64) | 2.32 | 0.00854 | 0.047122 |
GO:0065009 | regulation of molecular function | 3.12% (2/64) | 3.79 | 0.00931 | 0.047162 |
GO:0043603 | amide metabolic process | 4.69% (3/64) | 2.9 | 0.007788 | 0.047189 |
GO:0003824 | catalytic activity | 31.25% (20/64) | 0.79 | 0.007643 | 0.047235 |
GO:0016787 | hydrolase activity | 14.06% (9/64) | 1.36 | 0.007991 | 0.047485 |
GO:0043232 | intracellular non-membrane-bounded organelle | 6.25% (4/64) | 2.32 | 0.008536 | 0.047957 |
GO:0005618 | cell wall | 3.12% (2/64) | 3.86 | 0.008525 | 0.04878 |
GO:0032440 | 2-alkenal reductase [NAD(P)+] activity | 1.56% (1/64) | 6.89 | 0.008379 | 0.048853 |
GO:0097435 | supramolecular fiber organization | 3.12% (2/64) | 3.72 | 0.010332 | 0.049886 |